All of us are affected by covid19

Our friends and family got Covid, some survived. We pray for the spirit of those who died, may they rest in peace and forever be remembered by their love ones.

My niece, GF and insurance agent got positive test from covid, they rested and got well. All the time, we are worried for the worse might come. Thank God that they survived.

Today, one of my insurance agent in Socal was tested positive with Covid.

My tips: warm water with salt, Vitamin C, zinc, Vitamin B complex, Vitamin D and E, selenium, melatonin, magnesium and essential oil of euclyptus mixed in coconut oil.

Rest, be brave and strong and fight the virus with rest, sleep, warm drink of salt and other whole foods such as fresh pineapple, papaya, kiwi and beef broth with lots of garlic, ginger, carrots, apples, celery.

Warm drink: ginger, garlic, cayenne pepper, oregano, nutmeg, salt, turmeric

Stay in the sun during daytime.

Get well to us all.

CAN FOCUSED SOUND WAVES FIX RARE ‘GIGGLING’ FORM OF EPILEPSY?

New Blood Culture ID System Improves Care for Vets

New Blood Culture ID System Improves Care for Vets

Medical Technologist Dionne Hockett operates the new BioFire Blood Culture Identification system

Medical Technologist Dionne Hockett operates the new BioFire Blood Culture Identification system which allows doctors to detect harmful microorganisms in blood samples in just a few hours after blood cultures become positive.

By Chris Vadnais, Tennessee Valley Healthcare System Public Affairs Officer
Tuesday, February 20, 2018

VA Tennessee Valley Healthcare System (TVHS) doctors recently rolled out a new method to detect infectious agents in Veterans’ blood.

The newly-acquired BioFire Blood Culture Identification (BCID) system allows TVHS doctors to detect harmful microorganisms in blood samples in just a few hours after blood cultures become positive. The previous method could take three days.

“By detecting infectious agents more quickly and earlier in the course of infection, the patient can be given the correct antibiotics more quickly,” said Dr. Claudio Mosse, TVHS Chief of Pathology and Lab Service. “The use of broad-spectrum antibiotics should decrease also, as more targeted therapy is utilized once the target is identified,” he said.

Positive blood cultures are automatically sent to the new BioFire BCID system and tested for the 24 most common infectious agents found in the blood of septic patients. Because a positive blood culture could still contain a less-common microorganism — one the new system doesn’t detect — Dr. Mosse said all positive blood cultures are still processed through the older system as well.


Broad-spectrum antibiotics are associated with unintended side-effects. This new system will allow TVHS to reduce this risk through more targeted therapy. Targeted therapy is also likely to be more effective, meaning patients should be severely ill for less time.

“By getting on the correct antibiotics more quickly, patients should be able to get healthy more quickly and have less exposure to drugs that they don’t need,” said Dr. Mosse.

“Patients should be able to get healthy more quickly and have less exposure to drugs they don’t need.”

All this means TVHS can deliver a quicker, better response to a Veteran suffering from a serious blood infection.

“The safety of our Veterans is our primary goal,” said Erica Johnson-Lockett, TVHS Patient Safety Manager. “Targeting specific organisms and ensuring Veterans receive the right antibiotics in a timely fashion is in line with the National Patient Safety Goal regarding medication safety.” She said. “The BioFire BCID system is a prime example of TVHS’s commitment to patient safety.”

The BioFire BCID system is in operation at TVHS’s Nashville facility.

TVHS is an integrated tertiary health care system comprised of two hospitals, the Alvin C. York Campus in Murfreesboro and the Nashville Campus, as well as more than a dozen community-based outpatient clinics located in Tennessee and Kentucky. TVHS provides ambulatory care, primary care, and secondary care in acute medicine and surgery, specialized tertiary care, transplant services, spinal cord injury outpatient care, and a full range of extended care and mental health services.

Get a microalbumin/creatinine ratio – urine test to check your kidneys’s health

Test your kidneys’ health

When you are 40plus or having some health issues with your kidneys, it is best to get a urine test. I offer this test from LifeExtension via LabCorp. This test comes with free health coaching from me.

  • Connie Dello Buono
  • conniedbuono@gmail.com using paypal
    or via Venmo or Chase Bank Zelle , motherhealth@gmail.com , 408-854-1883
  • Cost: $73.33

LC140285 – MICROALBUMIN/CREATININE RATIO,RANDOM URINE (early morn to check your kidneys) New Item $73.33

Microalbuminuria is a term to describe a moderate increase in the level of urine albumin. It occurs when the kidney leaks small amounts of albumin into the urine, in other words, when there is an abnormally high permeability for albumin in the glomerulus of the kidney. Normally the kidneys filter albumin, so if albumin is found in the urine it’s then a marker of kidney disease. The term ‘microalbuminuria’ is now discouraged by KDIGO (Kidney Disease Improving Global Outcomes) and has been replaced by ‘moderately increased albuminuria’.

Associations/Indications

Microalbuminuria is an important adverse predictor of glycemic outcomes in pre-diabetes. Pre-diabetes individuals with increased microalbuminuria even in the so-called normal range is associated with increased progression to diabetes and decreased reversal to normoglycemia. Hence prediabetes individuals with microalbuminuria warrant more aggressive intervention to prevent diabetes in them.[2]

Causes/Prevention

Higher dietary intake of animal protein, animal fat, and cholesterol may increase risk for microalbuminuria,[3] and generally, diets higher in fruits, vegetables, and whole grains but lower in meat and sweets may be protective against kidney function decline.[4][5][6]

Diagnosis

The level of albumin protein produced by microalbuminuria can be detected by special albumin-specific urine dipsticks, which have a lower detection threshold than standard urine dipsticks. A microalbumin urine test determines the presence of the albumin in urine. In a properly functioning body, albumin is not normally present in urine because it is retained in the bloodstream by the kidneys.

Microalbuminuria can be diagnosed from a 24-hour urine collection (between 30–300 mg/24 hours) or, more commonly, from elevated concentration in a spot sample (20 to 200 mg/L). Both must be measured on at least two of three measurements over a two- to three-month period.[7]

An albumin level above the upper limit values is called “macroalbuminuria”, or sometimes just albuminuria. Sometimes, the upper limit value is given as one less (such as 300 being given as 299) to mark that the higher value (here 300) is defined as macroalbuminuria.[8]

To compensate for variations in urine concentration in spot-check samples, it is helpful to compare the amount of albumin in the sample against its concentration of creatinine. This is termed the albumin/creatinine ratio (ACR)[9] and microalbuminuria is defined as ACR ≥3.5 mg/mmol (female) or ≥2.5 mg/mmol (male),[10] or, with both substances measured by mass, as an ACR between 30 and 300 µg albumin/mg creatinine.[11] For the diagnosis of microalbuminuria, care must be taken when collecting sample for the urine ACR. An early morning sample is preferred. The patient should refrain from heavy exercises 24 hours before the test. A repeat test should be done 3 to 6 months after the first positive test for microalbuminuria. Lastly, the test is inaccurate in a person with too much or too little muscle mass. This is due to the variation in creatinine level which is produced by the muscle.[12]

Dutch Researchers Develop ThromboSeq Test to Detect Lung Cancer

Dutch Researchers Develop ThromboSeq Test to Detect Lung Cancer

A flock of starlings acting as a swarm

NEW YORK (GenomeWeb) – Researchers in the Netherlands have developed a diagnostic test to detect lung cancer by examining tumor RNA absorbed by circulating platelets called thrombocytes.

Published in Cancer Cell earlier today, the study investigated the potential and origin of spliced RNA profiles from tumor-educated platelets, or TEPs, for the noninvasive detection of early- and late-stage non-small cell lung cancer.

Platelets in patients that are cancer-free contain a different composition of RNA than TEPs, which are platelets that have interacted with a tumor.

The TEP gene panel developed by the scientists allows vector machine-based classification of lung cancer.

The researchers examined more than 700 blood samples using a biomarker signature detection platform called ThromboSeq, including patients diagnosed with late-stage non-small cell lung cancer, a smaller group with early stage cancer, and a control group with no known cancer.

ThromboSeq enables clinical researchers to identify different cancer types by looking at TEP-derived RNA using next-generation sequencing.

ThromboSeq’s swarm intelligence algorithm scanned approximately 5,000 different RNA molecules found in the thrombocytes and recorded the small amount that indicate a cancerous tumor. The researchers then ran the blood samples through screenings to diagnose how accurately the thrombocytes identified cancer.

According to the researchers, ThromboSeq detected early-stage cancer with 81 percent accuracy and late-stage cancer with 88 percent accuracy. The algorithm yielded an accuracy up to 91 percent in a validation control group that matched for a patient’s age, smoking status, and blood storage time.

The device’s particle-swarm optimization (PSO) algorithms allowed efficient selection of RNA biomarker panels from platelet RNA-sequencing libraries. The gene panels then diagnosed cancer from TEPs, suggesting that swarm intelligence may also benefit the optimization of diagnostic readout of other liquid biopsy biosources.

“ThromboSeq might not only provide lung cancer diagnostics, but potentially any other tumor type as well, and may enable tumor-type stratification,” VU University Medical Center researcher Myron Best said in a statement.

He and his colleagues based their method on swarming behavior that can be found in nature, where birds, insects, and fish swarm to defend themselves against predators or to search for food.

“Birds continuously adjust their location in the swarm relative to each other, thereby increasing the flock’s coverage, and thus, the efficiency of the food-searching process,” Best said. “We applied this natural phenomenon to our algorithms, which make use of the complex RNA repertoire present in platelets.”

Researchers concluded that the ThromboSeq platform allows for robust biomarker selection for blood-based cancer diagnostics, independent of bias introduced by factors such as age and smoking status. Best and his  team plan to further optimize the algorithm with patients suspected of having undiagnosed lung cancer.

“Although the tumor-educated platelets blood test does not, so far, provide perfect predictions, it may complement alternative liquid biopsy bio-sources” added Best.


Connie’s comments: Increase your anti-oxidant levels with yellow colored whole foods/supplements high in phytonutrients and greens.

To ORDER:  use Distributorship/sponsor ID #: USW9578356